Supplementary Figure 2: TERT expression analysis.
From: Genome-wide analysis of noncoding regulatory mutations in cancer
Expression differences between wild-type patient (without regulatory mutation) and patients affected by TERT promoter mutation for melanoma (top left), low-grade glioma (top right), glioblastoma (bottom left) and across all tumor types with TERT promoter mutation (bottom right). The wild-type (WT) set of samples in each panel consists of all samples without promoter mutation. The pan-cancer analysis excluded non-diploid samples from the wild-type cohort.
